BCBS Florida Medical Policy Updates – July 2019

Click here to view the Florida Blue Cross Blue Shield Medical Policy Updates »

July 2019 Medical Policy Updates:

• Advanced Imaging of the Heart: Echocardiography
• Arterial Ultrasound (Duplex Ultrasounds and Physiologic Testing)
• Axitinib (Inlyta®) Tablets
• Bendamustine HCl Injection
• Bevacizumab (Avastin®) Injection
• Bone Morphogenetic Protein (BMP)
• Bortezomib Injection
• Botulinum Toxins
• Caplacizumab-yhdp (Cablivi®)
• Cardiac Monitoring Devices
• Carfilzomib (Kyprolis®) Injection
• Certolizumab Pegol (Cimzia ) Injection
• Cervical Spine Surgery
• Cladribine (Mavenclad®) tablets
• Clotting Factors and Coagulant Blood Products
• Computed Tomographic (CT) Colonography (Virtual Colonoscopy)
• Daratumumab (Darzalex ) Injection
• Elotuzumab (Empliciti ) Injection
• Emapalumab-lzsg (Gamifant) IV
• Epidural Injections
• Erlotinib (Tarceva®) Tablets
• Erythropoiesis Stimulating Agents
• Facet Joint Injections
• Femoroacetabular Impingement (FAI) Syndrome Surgery (Open or Arthroscopic)
• Functional Neuromuscular Stimulation
• Genetic Testing
• Granulocyte Colony Stimulating Factors
• H.P. Acthar® Gel (Repository corticotropin)
• Hip Arthroplasty
• Hip Arthroscopy and Open, Non-Arthroplasty Hip Repair
• Home Pulse Oximetry
• Hydroxyprogesterone Caproate
• In Utero (Intrauterine) Fetal Surgery
• Infrared Energy Therapy and Low Level Laser Therapy
• Intravenous Enzyme Replacement Therapy for Gaucher Disease
• Investigational Services
• Ixazomib (Ninlaro ) Capsule
• Ixekizumab (Taltz ) Injection
• Keratoplasty and Keratectomy
• Knee Arthroplasty
• Knee Arthroscopy and Open, Non-Arthroplasty Knee Repair
• Laboratory Tests for Heart and Kidney Transplant Rejection
• Lanreotide (Somatuline® Depot) Injection
• Lenalidomide (Revlimid )
• Levoleucovorin (Fusilev  and Khapzory ) IV
• Lumbar Spine Surgery
• Manipulation Under Anesthesia
• Meniscal Allograft Transplantation
• Multiple Sclerosis Self Injectable Therapy
• Negative Pressure Wound Therapy (NPWT)
• Neurolysis/Ablation
• Octreotide Acetate (Sandostatin LAR® Depot) Injection
• Oral Therapy for Gaucher Disease
• Palonosetron Hydrochloride (Aloxi®)
• Panobinostat (Farydak ) Capsule
• Pasireotide (Signifor®, Signifor LAR®Injection
• Pegvaliase-pqpz (Palynziq )
• Pembrolizumab (Keytruda®) Injection
• Pomalidomide (Pomalyst ) Capsule
• Prosthetic Eyes and Lens Implants
• Pulmonary Hypertension Drug Therapy
• Ravulizumab (Ultomiris™) IV
• Siltuximab (Sylvant™) Injection
• Siponimod (Mayzent ) Tablets
• Technologies for the Evaluation of Malignant Melanoma
• Teduglutide (rDNA origin) (Gattex®) Injection
• Tetrabenazine (Xenazine) and Deutetrabenazine (Austedo)
• Thalidomide (Thalomid®) Caps
• Transcatheter Mitral Valve Repair (TMVR)
• Trastuzumab (Herceptin®) Injection
• Treatments for Varicose Veins/Venous Insufficiency
• Tumor/Genetic Markers
• Valbenazine (Ingrezza)
• Vascular Endothelial Growth Factor Inhibitors for Ocular Neovascularization

Click here to view the Florida Blue Cross Blue Shield Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.